Concerns regarding NGAL as a biomarker for heart failure without kidney disease
Journal of Cardiovascular and Thoracic Research · 30.03.2026 · 18 (1) · 69-70
DOI: 10.34172/jcvtr.026.33669 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cardiovascular and Thoracic Research, online erschienen am 30.03.2026. Verfasst von Çağrı Zorlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Tokat, Turkey. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
We appreciate the study by Asadolahi Mashhadian et al exploring NGAL as a biomarker for early heart failure (HF) diagnosis in patients without kidney disease. 1 However, several concerns regarding inconsistencies, literature discrepancies, and methodological limitations warrant clarification.The study claims patients had no kidney disease, with glomerular filtration rate (GFR) > 59 mL/min, yet reports significantly elevated creatinine (1.22 mg/dL vs. 0.23 mg/ dL, P 1.5 mg/dL, per citation 3), raising questions about patient selection criteria.How were "no kidney disease" patients defined, given these renal parameter elevations?Additionally, NGAL's predictive value for HF is significant in logistic regression (P = 0.002), but no correlation exists with cardiac troponin I (CTNI) or C-reactive protein (CRP), suggesting NGAL may reflect non-cardiac pathways, possibly renal stress.The study's findings contrast with literature indicating NGAL's elevations in HF are often linked to renal dysfunction or inflammation.2,3 Shrestha et al suggest NGAL is primarily driven by renal stress in HF 3 , which aligns with the elevated creatinine and BUN observed.Could the authors clarify how NGAL's role in HF was distinguished from renal involvement?Methodologically, the cross-sectional design limits claims of "early diagnosis, " as patients were already diagnosed with HF with reduced ejection fraction (EF < 40%).A prospective study would better support early detection claims.The assumption of data normality lacks justification, and the logistic regression model's wide confidence interval for creatinine (0.302-1426.701)
Autor:innen und Institutionen
- Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Tokat, Turkey.
ORCID-Profile: Çağrı Zorlu, Sefa Erdi Ömür
Zitieren
APA
Zorlu, Ç., & Ömür, S. E. (2026). Concerns regarding NGAL as a biomarker for heart failure without kidney disease. Journal of Cardiovascular and Thoracic Research, 18(1), 69-70. https://doi.org/10.34172/jcvtr.026.33669
Vancouver
Zorlu Ç, Ömür SE. Concerns regarding NGAL as a biomarker for heart failure without kidney disease. Journal of Cardiovascular and Thoracic Research. 2026;18(1):69-70. doi:10.34172/jcvtr.026.33669
BibTeX
@article{Zorlu2026,
author = {Zorlu, Çağrı and Ömür, Sefa Erdi},
title = {Concerns regarding NGAL as a biomarker for heart failure without kidney disease},
journal = {Journal of Cardiovascular and Thoracic Research},
year = {2026},
volume = {18},
number = {1},
pages = {69--70},
doi = {10.34172/jcvtr.026.33669}
}
EUVIMED